|
2025
|
Invention
|
Typing and assembling discontinuous genomic elements.
This invention relates to methods and kits... |
|
|
Invention
|
Dimerization pairs and uses thereof. Provided herein are dimerization pairs comprising a first an... |
|
2024
|
Invention
|
Methods for identifying high avidity t cell receptors or t cells. This disclosure describes metho... |
|
|
Invention
|
Heterodimeric proteins comprising dimerization motifs and methods of using. Provided herein are h... |
|
|
Invention
|
Methods and systems for identifying clinically relevant t-cell receptors. in-silicoin-silico pred... |
|
|
Invention
|
Whole-genome haplotype reconstruction.
The present invention relates to methods for haplotype de... |
|
|
Invention
|
Method for suppressing car-t cells unresponsiveness for improving cancer immunotherapy. The inven... |
|
|
Invention
|
Bisulfite-free, base-resolution identification of cytosine modifications.
This disclosure provid... |
|
|
Invention
|
Modification of pseudouridine. A 2-bromoacrylamide-assisted cyclization sequencing (BACS) method ... |
|
2023
|
Invention
|
Genome-wide identification of chromatin interactions.
Methods and kits for genome-wide identific... |
|
|
Invention
|
Expansion of lymphocytes. The present invention relates to a method for expansion of a population... |
|
|
Invention
|
Methods of treating neoplastic astrocytoma.
The present invention relates to specific binding me... |
|
|
Invention
|
Anti-ctla-4 antibodies and methods of use thereof. The instant disclosure provides antibodies tha... |
|
|
Invention
|
Methods and systems for analyzing chromatins.
This disclosure provides a novel method and system... |
|
|
Invention
|
Methods and systems for analyzing chromatins. in situde novode novo in interphase cells. |
|
|
Invention
|
Use of urolithin in the remission phase of a preceding cancer therapy.
The current invention is ... |
|
|
Invention
|
Use of urolithin in the remission phase of a preceding cancer therapy. The current invention is d... |
|
2022
|
Invention
|
Antisense transfer vectors and methods of use thereof.
The present disclosure describes a next-g... |
|
|
Invention
|
Antisense transfer vectors and methods of use thereof. The present disclosure describes a next-ge... |
|
|
Invention
|
Methods for predicting responsiveness to a cancer therapy. e.g.e.g., adoptive cell therapy (ACT))... |
|
|
Invention
|
Methods of administering anti-ox40 antibodies.
The present disclosure provides antibodies that s... |
|
|
Invention
|
Antibodies and methods of use thereof.
The present disclosure provides multispecific (e.g., bisp... |
|
|
Invention
|
Compositions and methods related to tet-assisted pyridine borane sequencing for cell-free dna.
T... |
|
|
Invention
|
Use of methanol and prodrugs thereof in therapy.
Provided herein are methods of using methanol, ... |
|
|
Invention
|
T cell receptors specific for tumor-associated antigens and methods of use thereof.
This disclos... |
|
|
Invention
|
T cell receptors specific for tumor-associated antigens and methods of use thereof. This disclosu... |
|
|
Invention
|
Anti-gitr antibodies and methods of use thereof.
The present disclosure provides antibodies that... |
|
|
Invention
|
Methods and compositions for detecting ecdna.
Provided herein, inter alia, are methods of detect... |
|
|
Invention
|
Anti-ox40 antibodies, anti-gitr antibodies, and methods of use thereof.
The present disclosure p... |
|
|
Invention
|
Anti-pd-1 antibodies and methods of use thereof.
The instant disclosure provides antibodies that... |
|
|
Invention
|
Compositions and methods for immunotherapy.
The present disclosure relates to methods and compos... |
|
|
Invention
|
Compositions and methods for immunotherapy. The present disclosure relates to methods and composi... |
|
|
Invention
|
Urolithin for increasing stem cell function.
Use of a urolithin for increasing stem cell functio... |
|
|
Invention
|
Urolithin for increasing stem cell function. Use of a urolithin for increasing stem cell function... |
|
|
Invention
|
Single vessel expansion of lymphocytes.
The present invention relates to a population of lymphoc... |
|
|
Invention
|
Single vessel expansion of lymphocytes. The present invention relates to a population of lymphocy... |
|
|
Invention
|
Anti-tem1 antibodies and antigen-binding portions thereof. Provided herein are antibodies and ant... |
|
|
Invention
|
Bisulfite-free, base-resolution identification of cytosine modifications. This disclosure provide... |
|
|
P/S
|
Pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for use in immun... |
|
|
P/S
|
Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms ... |
|
2021
|
Invention
|
Pd-1 decoy variants for immunotherapy.
The present disclosure relates to novel PD-1 decoy varian... |
|
|
Invention
|
Compositions and methods for increasing stem cell function.
Use of a composition comprising a co... |
|
|
Invention
|
Cytosine modification analysis.
Among other things, the present disclosure provides compositions... |
|
|
Invention
|
Parallel analysis of individual cells for rna expression and dna from targeted tagmentation by se... |
|
|
Invention
|
Targeted, long-read nucleic acid sequencing for the determination of cytosine modifications.
The... |
|
2020
|
Invention
|
Car-t cell therapy targeting ngcgm3.
The invention relates to chimeric antigen receptors (CARs) ... |
|
|
Invention
|
Bisulfite-free, whole genome methylation analysis. This disclosure provides methods for cost-effe... |
|
2018
|
P/S
|
Cells for scientific, laboratory or medical research; Chemical, biochemical and biotechnological ... |
|
|
P/S
|
Cells for scientific, laboratory or medical research; Chemicals used in industry and science; bio... |
